Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 301–315 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-44 Genetic Test This test identifies genetic variants associated with hereditary dystonia, a neurological movement disorder.	Whole blood (EDTA)	40 working days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants in dystonia-associated genes", "Diagnostic sensitivity"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting a physician"] Indications ["Suspected hereditary dystonia", "Need for comprehensive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94277-6 ICD-10: G24.9 Clinical summary This test identifies genetic variants associated with hereditary dystonia, a neurological movement disorder.
TEST-242 Genotyping by Sequencing (96‑Sample Batch) Test This test performs genome-wide genotyping on up to 96 DNA samples using Next-Generation Sequencing.	Whole Blood (Peripheral) or Extracted DNA (≥2 µg, A260/280 1.8–2.0)	5 weeks from sample receipt	50,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)", "Genome-wide variant calling"] Parameters [] Preparation [] Indications ["Oncology research", "Pharmacogenomics", "Population studies", "Susceptibility screening"] Measurement technique Confirm with laboratory Codes LOINC: 77949-2 ICD-10: Z13.89 Clinical summary This test performs genome-wide genotyping on up to 96 DNA samples using Next-Generation Sequencing.
TEST-281 Genotyping by Sequencing and Primary Analysis (96 Samples) Test This test identifies genetic alterations in a customized gene panel using next-generation sequencing.	Peripheral Whole Blood (EDTA or ACD tubes)	8 Weeks from sample receipt	60,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants", "Insertions", "Deletions", "Copy-number changes"] Parameters [] Preparation [] Indications ["Precision medicine decisions in oncology", "Precision medicine decisions in rheumatology", "Clinical research"] Measurement technique Confirm with laboratory Codes LOINC: 47979-3 ICD-10: Z13.9 Clinical summary This test identifies genetic alterations in a customized gene panel using next-generation sequencing.
TEST-167 Genotyping by Sequencing Primary Data Analysis (96 Samples) Test This test analyzes primary sequencing data from 96 DNA samples using NGS to identify genetic variants relevant to cancer, autoimmune disorders, and research.	Whole Blood (Peripheral)	4 weeks	17,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants", "Mutations associated with cancer", "Mutations associated with autoimmune disorders"] Parameters [] Preparation ["No special preparation such as fasting is required"] Indications ["Identification of genetic variants associated with cancer", "Identification of genetic variants associated with autoimmune disorders", "Research targets"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Z13.79, Z13.89 Clinical summary This test analyzes primary sequencing data from 96 DNA samples using NGS to identify genetic variants relevant to cancer, autoimmune disorders, and research.
TEST-4446 GJA5 Gene Atrial Fibrillation Type 11 Genetic Test This test evaluates the GJA5 gene for pathogenic variants associated with familial atrial fibrillation type 11.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJA5 gene", "Coding exons and splice sites"] Parameters [] Preparation [] Indications ["Individuals with a family history of familial atrial fibrillation type 11", "Risk assessment for inherited cardiac conditions"] Measurement technique Confirm with laboratory Codes LOINC: 91245-5 ICD-10: I48.91 Clinical summary This test evaluates the GJA5 gene for pathogenic variants associated with familial atrial fibrillation type 11.
TEST-5183 GJB6 Gene Ectodermal Dysplasia, Hidrotic Genetic Test This genetic test analyzes the GJB6 gene to identify mutations associated with hidrotic ectodermal dysplasia (Clouston syndrome). It provides a definitive molecular diagnosis for i...	Peripheral Whole Blood (EDTA)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in GJB6 gene", "Small indels in GJB6 gene", "Copy number alterations in GJB6 gene"] Parameters [] Preparation ["No fasting required", "No medication changes required unless directed by physician", "Complete clinical history questionnaire", "Attend genetic counselling session"] Indications ["Diagnosis of hidrotic ectodermal dysplasia (Clouston syndrome)", "Genetic counselling for families with affected individuals", "Reproductive planning for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 79000-7 ICD-10: Q82.8 Clinical summary This genetic test analyzes the GJB6 gene to identify mutations associated with hidrotic ectodermal dysplasia (Clouston syndrome). It provides a definitive molecular diagnosis for individuals with symptoms or those at risk.
TEST-1563 Glioma Panel (MGMT, IDH1&2, FISH 1p19q) Test The Glioma Panel simultaneously evaluates MGMT promoter methylation, IDH1/2 hotspot mutations, and chromosome 1p/19q codeletion.	Tumour tissue (biopsy or surgical resection)	14–21 calendar days	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MGMT promoter methylation status", "IDH1/2 hotspot mutations", "Chromosome 1p/19q codeletion"] Parameters [{"name": "MGMT promoter methylation status", "reference_range": null}, {"name": "IDH1/2 hotspot mutations", "reference_range": null}, {"name": "Chromosome 1p/19q codeletion", "reference_range": null}] Preparation [] Indications ["Diagnosis and classification of diffuse gliomas", "Prognosis assessment", "Prediction of response to temozolomide chemotherapy"] Measurement technique Confirm with laboratory Codes LOINC: 92011-4 ICD-10: C71.9, D43.2 Clinical summary The Glioma Panel simultaneously evaluates MGMT promoter methylation, IDH1/2 hotspot mutations, and chromosome 1p/19q codeletion.
TEST-1359 Glioma Prognostic Panel (NGS & PCR) Test This test evaluates key genetic and epigenetic markers in glioma tumour tissue using NGS and PCR.	Archival Tissue Specimen (FFPE Tissue Block)	15 working days from FFPE block receipt by 11:00 AM	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IDH1/2 mutations", "TERT promoter mutations", "1p/19q codeletion", "MGMT promoter methylation"] Parameters [{"name": "IDH1/2 mutations", "reference_range": null}, {"name": "TERT promoter mutations", "reference_range": null}, {"name": "1p/19q codeletion", "reference_range": null}, {"name": "MGMT promoter methylation", "reference_range": null}] Preparation [] Indications ["Diagnosis of glioma", "Prognosis assessment for glioma", "Treatment planning for glioma", "Clinical trial eligibility assessment"] Measurement technique Confirm with laboratory Codes LOINC: 63332-3 ICD-10: C71.9 Clinical summary This test evaluates key genetic and epigenetic markers in glioma tumour tissue using NGS and PCR.
TEST-6324 GLIS3 Gene Diabetes Mellitus, Neonatal (Genetic Test) This genetic test identifies pathogenic variants in the GLIS3 gene associated with permanent neonatal diabetes mellitus.	Whole blood (2–3 mL) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GLIS3 gene pathogenic variants", "Copy number variants in GLIS3 gene"] Parameters [] Preparation [] Indications ["Infants presenting with hyperglycemia before six months of age", "Suspected monogenic diabetes"] Measurement technique Confirm with laboratory Codes LOINC: 21619-7 ICD-10: P70.2 Clinical summary This genetic test identifies pathogenic variants in the GLIS3 gene associated with permanent neonatal diabetes mellitus.
TEST-3330 GLRX5 Gene NGS Test for Pyridoxine‑Refractory Sideroblastic Anemia This test evaluates the GLRX5 gene for pathogenic variants associated with autosomal recessive pyridoxine‑refractory sideroblastic anemia.	Peripheral Whole Blood or Buccal Swab	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GLRX5 gene sequence", "Pathogenic variants in GLRX5"] Parameters [] Preparation ["No fasting required", "Inform lab of recent blood transfusions or stem cell transplant"] Indications ["Diagnosis of pyridoxine‑refractory sideroblastic anemia", "Family risk stratification", "Informed reproductive decision-making"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: D64.0 Clinical summary This test evaluates the GLRX5 gene for pathogenic variants associated with autosomal recessive pyridoxine‑refractory sideroblastic anemia.
TEST-1281 Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Mutation Detection Test This test identifies specific genetic mutations in the G6PD gene responsible for G6PD deficiency.	Peripheral Whole Blood	10 Business Days (Monday sample before 11:00 AM)	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the G6PD gene"] Parameters [] Preparation ["No fasting or special preparation is required", "Avoid blood transfusions for 3 months prior if possible"] Indications ["At-risk individuals", "Pre-chemotherapy pharmacogenetic screening", "Neonatal jaundice evaluation", "Family history of G6PD deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 21660-8 ICD-10: D55.0 Clinical summary This test identifies specific genetic mutations in the G6PD gene responsible for G6PD deficiency.
TEST-1559 Glycogen Storage Disorder Gene Panel Test This test identifies pathogenic variants in genes associated with glycogen metabolism using Next-Generation Sequencing.	Peripheral blood (whole blood in EDTA); prenatal: amniotic fluid or CVS	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in over 30 genes related to glycogen metabolism", "Full gene coverage including deep intronic regions"] Parameters [] Preparation ["Inform the phlebotomist of all medications, including over-the-counter supplements"] Indications ["Suspected diagnosis of Glycogen Storage Disorder", "Confirmation of GSD diagnosis", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 95209-3 ICD-10: E74.0, E74.09, E74.01 Clinical summary This test identifies pathogenic variants in genes associated with glycogen metabolism using Next-Generation Sequencing.
TEST-346 GMO Detection Test This test detects the presence of genetically modified DNA sequences in corn and soy food products.	Corn & Soy Flour, Grits, Meal, Flakes (product sample)	5–7 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetically modified DNA sequences in corn and soy"] Parameters [{"name": "GMO DNA Detection", "reference_range": "Negative (below 0.9% GMO)"}] Preparation [] Indications ["Food product non-GMO verification", "Dietary purity validation for longevity protocols", "Assessment of potential inflammatory triggers"] Measurement technique Confirm with laboratory Codes LOINC: 101844-0 ICD-10: Z91.012, Z91.014, Z13.29 Clinical summary This test detects the presence of genetically modified DNA sequences in corn and soy food products.
TEST-4257 GNAL (DYT25) Genetic Test This test identifies pathogenic variants in the GNAL gene, which are associated with isolated dystonia.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GNAL gene", "Copy Number Variations (CNVs) in the GNAL gene"] Parameters [] Preparation [] Indications ["Clinical diagnosis of isolated dystonia", "Family risk assessment for dystonia", "Personalized management of dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 48000-4 ICD-10: G24.1 Clinical summary This test identifies pathogenic variants in the GNAL gene, which are associated with isolated dystonia.
TEST-3143 GP1BA Gene Sequencing for von Willebrand Disease Platelet Type (NGS) Test This test identifies genetic mutations in the GP1BA gene associated with platelet-type von Willebrand disease.	Peripheral whole blood (EDTA) or buccal swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GP1BA gene mutations", "Platelet-type von Willebrand disease (PT-VWD)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all medications"] Indications ["Suspected platelet-type von Willebrand disease", "Family history of bleeding disorders", "Need for precise diagnosis of inherited bleeding disorder"] Measurement technique Confirm with laboratory Codes LOINC: 48066-2 ICD-10: D68.0 Clinical summary This test identifies genetic mutations in the GP1BA gene associated with platelet-type von Willebrand disease.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories